.jpg?w=340&itok=2YCoyXLm "IPT discussed in technical publications."){kind=icon}
.jpg?w=340&itok=_weN-aN8 "IPT discussed in technical publications."){kind=icon}
Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
The surge of digital health technologies modernising clinical research
Dr. Isaac R. Rodriguez-Chavez outlines the key considerations when developing digital health technologies.
-
Precision medicine
Ewa Kleczyk, Vice President, Advanced & Custom Analytics, offers her insights on the use of precision medicine in clinical trials.
-
The silent problem: Machine learning model failure - How to diagnose and fix ailing machine learning models
This article considers the current issues around the applicability of Machine Learning Models.
Bennett, M. Balusu, J., Hayes, K., & Klecyzk, E. J., The Silent Problem- Machine Learning Model Failure - How to Diagnose and Fix Ailing Machine Learning Models. Cornell University ArxIV. doi: 10.48550/arXiv.2204.10227
-
-
How healthcare can develop through digital innovation
Gerard Quinn and Barbara Skerritt offer their insights into the rapid acceleration of digital innovation in clinical research in the past two years.
-
.jpg?w=545&itok=qxBSkGrj "IPT discussed in technical publications.")
The path to smarter digital health
Michael Phillips and Kevin Rooney discuss the use of artificial intelligence for the purposes of automation in digital health and pharma.
This article is taken from Innovations in Pharmaceutical Technology Autumn/Winter 2021, pages 39-41. Samedan Ltd
-
Data Science: transforming the future of clinical trials
Gerard Quinn, VP of IT Innovation & Informatics, offers insights on the use of Machine Learning and Artificial Intelligence in clinical trials, and the potential benefits and challenges for CROs and sponsors (pages 16-17).
-
Pharma’s digital transformation – How to best incorporate wearables amid an evolving landscape
A thought leadership piece which examines how disruptions from COVID-19 have forced sponsors, clinicians and regulators to embrace digital's full potential to keep clinical trials moving forward.
-
Decentralised & hybrid trials: The future of clinical trials post pandemic
An interview with EB McLindon, Senior VP, Patient, Site & Decentralised Solutions, on why the future of drug development involves decentralising parts of the clinical trial process.
-
.jpg?w=545&itok=WjjDeARM "IPT discussed in technical publications.")
Data capture in a post-digital clinical trial landscape
A thought leadership article authored by Tom O’Leary on how collected data from digital health technologies, coupled with novel clinical trial models, have the ability to increase the value proposition of drugs and medical devices.
This article is taken from Innovations in Pharmaceutical Technology Autumn/Winter 2020, pages 38-40. © Samedan Ltd
